Smoking CessationNCT07075263
Smoking Among Resident Physician and Their Role in Smoking Cessation Advice
An observational study of Smoking Cessation, run by Mansoura University Hospital at 1 site in Egypt.
Trial summary
smoking is a key modifiable risk factor that greatly increases the likelihood of 2 dying young from cancer, heart disease, and lung disorders The World Health Organization (WHO) reports that 3 tobacco products are used by one-third of the world's population, and that 90% of tobacco users began using 4 them before the… Read more about this study
- Who is it for?
- Any age
- Conditions the study is for
- Smoking Cessation
- What is being tested?
- Questionnaire
- How many people
- 225 participants
- Where
- 1 siteEgypt
- Study dates
- 1 Aug 2023to 1 Aug 2024
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages Any age
- All sexes
- No healthy volunteers
- Child, Adult, Older adult
Study population: This study included the whole total resident physicians number at Mansoura university hospital in 2023
Who may be able to join
- whole total resident physicians number at Mansoura university hospital in 2023
Who cannot join
- refuse to share or had a vacation from work
Trial locations and contacts
1 site in 1 country.
About this study
smoking is a key modifiable risk factor that greatly increases the likelihood of 2 dying young from cancer, heart disease, and lung disorders The World Health Organization (WHO) reports that 3 tobacco products are used by one-third of the world's population, and that 90% of tobacco users began using 4 them before the age of 18.
Read the detailed description
The majority of smokers make multiple unsuccessful attempts to stop 5 smoking before attaining long-term abstinence, with over half of these attempts culminating in a relapse. 6 Healthcare professionals are essential in helping people stop smoking. According to professional guidelines and 7 the World Health Organization (WHO), doctors should actively encourage smokers to give up. Aim of this work 8 was to explore the knowledge, attitude and practice of resident physicians about smoking cessation program and 9 the effect of their smoking habits on smoking cessation advice for patients.
- Conditions
- Smoking Cessation
- Being tested
- Questionnaire
- Keywords
- Smoking, Smoking cessation, Resident physicians
- Medical subject headings
- Smoking Cessation, Smoking
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
QuestionnaireOther
A self-administered structured questionnaire
| Study group | Role | What they receive |
|---|---|---|
| Resident physicians | whole total resident physicians number at Mansoura university hospital in 2023 Receives: Other: Questionnaire |
What is being measured
The primary outcome is the main question the study is designed to answer.
Smoking cessation awareness
questions which cover counseling or receiving of therapy for smoking cessation.
Measured: 6 months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted20 Jul 2025
- Study start1 Aug 2023
- Primary completion1 Feb 2024
- Study completion1 Aug 2024
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Smoking CessationStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Case only
- Time perspective
- Cross-sectional
- Enrolment
- 225 participants (actual)
Sponsor and investigators
- Lead sponsor
- Mansoura University Hospital
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Mohamed Abd Elmoniem Mohamed, Mansoura University Hospital
- Investigators
- Mohamed AbdElmoniem, Principal investigator, Lecturer of chest medicine faculty of medicine Mansoura university
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07075263
- Sponsor's protocol ID
- MS.21.05.1492
- Status last verified
- Jul 2025
- First submitted
- 11 Jul 2025
- Last updated
- 20 Jul 2025
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 20 Jul 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Smoking Among Resident Physician and Their Role in Smoking Cessation Advice
- ClinicalTrials.gov ID
- NCT07075263
- Acronym / sponsor ID
- MS.21.05.1492
- Conditions
- Smoking Cessation
- Keywords
- Smoking, Smoking cessation, Resident physicians
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 225 participants (actual)
- Lead sponsor
- Mansoura University HospitalUniversity, hospital or other
- Study start
- 1 Aug 2023 (actual)
- Primary completion
- 1 Feb 2024 (actual)
- Study completion
- 1 Aug 2024 (actual)
- First posted
- 20 Jul 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
smoking is a key modifiable risk factor that greatly increases the likelihood of 2 dying young from cancer, heart disease, and lung disorders The World Health Organization (WHO) reports that 3 tobacco products are used by one-third of the world's population, and that 90% of tobacco users began using 4 them before the age of 18.
Detailed description
The majority of smokers make multiple unsuccessful attempts to stop 5 smoking before attaining long-term abstinence, with over half of these attempts culminating in a relapse. 6 Healthcare professionals are essential in helping people stop smoking. According to professional guidelines and 7 the World Health Organization (WHO), doctors should actively encourage smokers to give up. Aim of this work 8 was to explore the knowledge, attitude and practice of resident physicians about smoking cessation program and 9 the effect of their smoking habits on smoking cessation advice for patients.
Study design
- Observational model
- Case only
- Time perspective
- Cross-sectional
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Resident physicians | – | Other: Questionnairewhole total resident physicians number at Mansoura university hospital in 2023 |
Who may qualify
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Child, Adult, Older adult
- Study population
- This study included the whole total resident physicians number at Mansoura university hospital in 2023
Key inclusion criteria (1 listed)
- whole total resident physicians number at Mansoura university hospital in 2023
Key exclusion criteria (1 listed)
- refuse to share or had a vacation from work
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| QuestionnaireA self-administered structured questionnaire | Other | Resident physicians |
Primary outcome
Smoking cessation awareness
Time frame: 6 months
questions which cover counseling or receiving of therapy for smoking cessation.
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 20 Jul 2025.
Related trials for Smoking Cessation
Recruiting
Scalable TELeheaLth Cancer CARe: The STELLAR Program to Treat Cancer Risk Behaviors
Obesity, Smoking Cessation
Not yet recruiting
Smoking Cessation Program for Lao People With HIV
Smoking Cessation, HIV
RecruitingPhase 3
Studying NMDA and Sigma-1 in Smoking Cessation Treatment (SUMMIT)
Smoking Cessation
Not yet recruiting
Impacto 2.0: Mobile Smoking Cessation Across Texas
Cigarette Smoking, Smoking Cessation
Not yet recruitingObservational study
PROMETHEE: A Shared Interregional Tele-Tobacco Cessation Platform Embedded Within the IMPULSION Lung Cancer Screening Program
Smoking Cessation, Lung Cancer Screening
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Mohamed AbdElmoniem principal investigator
Lecturer of chest medicine faculty of medicine Mansoura university
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Smoking Cessation, run by Mansoura University Hospital at 1 site in Egypt.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 20 Jul 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Smoking cessation awareness (time frame: 6 months). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 20 Jul 2025; AzTrials last refreshed its copy on 8 Nov 2026.